Literature DB >> 23996285

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).

Lars Rydén, Peter J Grant, Stefan D Anker, Christian Berne, Francesco Cosentino, Nicolas Danchin, Christi Deaton, Javier Escaned, Hans-Peter Hammes, Heikki Huikuri, Michel Marre, Nikolaus Marx, Linda Mellbin, Jan Ostergren, Carlo Patrono, Petar Seferovic, Miguel Sousa Uva, Marja-Riita Taskinen, Michal Tendera, Jaakko Tuomilehto, Paul Valensi, Jose Luis Zamorano, Jose Luis Zamorano, Stephan Achenbach, Helmut Baumgartner, Jeroen J Bax, Héctor Bueno, Veronica Dean, Christi Deaton, Cetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Ales Linhart, Petros Nihoyannopoulos, Massimo F Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Luis Tamargo, Michal Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Guy De Backer, Per Anton Sirnes, Eduardo Alegria Ezquerra, Angelo Avogaro, Lina Badimon, Elena Baranova, Helmut Baumgartner, John Betteridge, Antonio Ceriello, Robert Fagard, Christian Funck-Brentano, Dietrich C Gulba, David Hasdai, Arno W Hoes, John K Kjekshus, Juhani Knuuti, Philippe Kolh, Eli Lev, Christian Mueller, Ludwig Neyses, Peter M Nilsson, Joep Perk, Piotr Ponikowski, Zeljko Reiner, Naveed Sattar, Volker Schächinger, André Scheen, Henrik Schirmer, Anna Strömberg, Svetlana Sudzhaeva, Juan Luis Tamargo, Margus Viigimaa, Charalambos Vlachopoulos, Robert G Xuereb.   

Abstract

Entities:  

Keywords:  Cardiovascular disease; Coronary Interventions; Diabetes mellitus; Diagnostics; Epidemiology; Guidelines; Impaired glucose tolerance; Patient management; Pharmacological treatment; Prevention; Prognosis; Risk factors

Mesh:

Substances:

Year:  2013        PMID: 23996285     DOI: 10.1093/eurheartj/eht108

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  559 in total

Review 1.  The role of lifestyle change for prevention of cardiovascular disease in diabetes.

Authors:  Lisa R Staimez; Mary Beth Weber; Edward W Gregg
Journal:  Curr Atheroscler Rep       Date:  2014-12       Impact factor: 5.113

Review 2.  Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?

Authors:  Dick C Chan; Jing Pang; Gerald F Watts
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

3.  10-year incidence of diabetes and associated risk factors in Greece: the ATTICA study (2002-2012).

Authors:  Efi Koloverou; Demosthenes B Panagiotakos; Christos Pitsavos; Christina Chrysohoou; Ekavi N Georgousopoulou; Evangelia Pitaraki; Vassiliki Metaxa; Christodoulos Stefanadis
Journal:  Rev Diabet Stud       Date:  2014-08-10

4.  Screening asymptomatic patients with type 2 diabetes is recommended: Pro.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2015-09-21       Impact factor: 5.952

5.  Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population.

Authors:  A S Meijnikman; C E M De Block; E Dirinck; A Verrijken; I Mertens; B Corthouts; L F Van Gaal
Journal:  Int J Obes (Lond)       Date:  2017-07-19       Impact factor: 5.095

Review 6.  The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox.

Authors:  Demetrios Moris; Michael Spartalis; Eleftherios Spartalis; Georgia-Sofia Karachaliou; Georgios I Karaolanis; Gerasimos Tsourouflis; Diamantis I Tsilimigras; Eleni Tzatzaki; Stamatios Theocharis
Journal:  Ann Transl Med       Date:  2017-08

Review 7.  Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group.

Authors:  Dominique Hansen; Josef Niebauer; Veronique Cornelissen; Olga Barna; Daniel Neunhäuserer; Christoph Stettler; Cajsa Tonoli; Eugenio Greco; Robert Fagard; Karin Coninx; Luc Vanhees; Massimo F Piepoli; Roberto Pedretti; Gustavo Rovelo Ruiz; Ugo Corrà; Jean-Paul Schmid; Constantinos H Davos; Frank Edelmann; Ana Abreu; Bernhard Rauch; Marco Ambrosetti; Simona Sarzi Braga; Paul Beckers; Maurizio Bussotti; Pompilio Faggiano; Esteban Garcia-Porrero; Evangelia Kouidi; Michel Lamotte; Rona Reibis; Martijn A Spruit; Tim Takken; Carlo Vigorito; Heinz Völler; Patrick Doherty; Paul Dendale
Journal:  Sports Med       Date:  2018-08       Impact factor: 11.136

8.  Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Authors:  Csaba P Kovesdy; Kunihiro Matsushita; Yingying Sang; Nigel J Brunskill; Juan J Carrero; Gabriel Chodick; Takeshi Hasegawa; Hiddo L Heerspink; Atsushi Hirayama; Gijs W D Landman; Adeera Levin; Dorothea Nitsch; David C Wheeler; Josef Coresh; Stein I Hallan; Varda Shalev; Morgan E Grams
Journal:  Eur Heart J       Date:  2018-05-01       Impact factor: 29.983

Review 9.  The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Tomohiro Suhara; Yuichi Baba; Briana K Shimada; Jason K Higa; Takashi Matsui
Journal:  Curr Diab Rep       Date:  2017-06       Impact factor: 4.810

10.  Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress.

Authors:  Gábor Koncsos; Zoltán V Varga; Tamás Baranyai; Kerstin Boengler; Susanne Rohrbach; Ling Li; Klaus-Dieter Schlüter; Rolf Schreckenberg; Tamás Radovits; Attila Oláh; Csaba Mátyás; Árpád Lux; Mahmoud Al-Khrasani; Tímea Komlódi; Nóra Bukosza; Domokos Máthé; László Deres; Monika Barteková; Tomáš Rajtík; Adriana Adameová; Krisztián Szigeti; Péter Hamar; Zsuzsanna Helyes; László Tretter; Pál Pacher; Béla Merkely; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-08-12       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.